In Focus
Can Saudi insurers protect profits without owning healthcare providers?
Can Saudi insurers protect profits without owning healthcare providers?
Rising claim costs continue to outpace premium growth.
1 day ago
Global GLP-1 market on track for $133.92b by 2034
Asia Pacific is projected to post the fastest regional growth.
2 days ago
China's internet healthcare pivots to AI disease management
New prescription rules favour compliant platforms as regulations tighten.
5 days ago
China’s 15th Five‑Year Plan elevates medtech, brain‑computer interfaces
AI adoption in medtech is also moving from policy to practice.
6 days ago
Malaysia healthcare kept at Market Weight as earnings outpace revenue
Hospital revenue growth is projected at 12.4% in 2026.
Saudi insurers urged to enter care provision as profit gap widens
Gap persists despite strong market growth.
Will Japan's healthcare funding stop record closures?
Most reimbursement increases are going to hospitals as provider failures keep rising.
AI in pharma market to hit $28.6b by 2034 on drug discovery push
Asia Pacific is set to post the fastest growth.
Ageing, chronic diseases push APAC medtech towards $132b by 2030
Despite this, few companies in the region have scaled globally.
China’s healthcare defies Hang Seng slump with 0.9% gain
Investor sentiment, however, weakened during the second quarter.
How can healthcare providers make AI pay off?
Most organisations are still breaking even on technology spending.
China's healthcare sector set for global breakout
Greater China completed 186 cross-border biotech out-licensing deals in 2025.
How can Asia-Pacific prove medical research is worth the money?
Study finds inconsistent methods can distort funding decisions.
Obesity drains $45b annually from Australia’s economy
Nearly 240,000 Australians can not work due to obesity-related factors.
APAC turns to AI as healthcare worker shortfall nears 11 million
Medical inflation nearing 12% in 2025 pushes hospitals toward digital tools.
Medical inflation rises to 11.3% as employers face cost squeeze
One-third of regional markets posted lower healthcare price trends.
How far can institutional capital shape digital health innovation?
Scale increasingly depends less on venture capital backing.
Commentary
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings